Dyadic International Inc
DYAI
NASDAQ
Biotechnology
$0.78
USD
+0.01 (+0.65%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $28.40M
Volume 164.2K
Revenue
$3.80M
TTM
-8.0%
YoY
Gross Margin
16%
TTM
-72.9%
YoY
Net Income
$-7.62M
TTM
-36.7%
YoY
Operating Cash Flow
$-7.40M
TTM
-148.7%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 1.0 | 1.2 | 0.6 | 1.1 | 1.0 |
YoY Growth | +150.5% | -40.5% | -30.8% | +182.3% | -0.6% |
Cost of Revenue | 0.6 | 1.0 | 0.4 | 0.8 | 1.0 |
Gross Profit | 0.4 | 0.1 | 0.2 | 0.3 | -0.0 |
Selling, General & Administrative | 1.4 | 1.5 | 1.2 | 1.8 | 1.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 2.1 | 2.1 | 1.7 | 2.2 | 2.0 |
Operating Income | -1.7 | -1.9 | -1.5 | -1.9 | -2.0 |
EBITDA | -1.7 | -1.9 | -1.5 | -1.9 | -2.1 |
Other Income / Expense | -0.0 | -0.0 | -0.0 | 0.0 | -0.0 |
Total Other Income / Expense | -0.1 | -0.1 | -0.0 | -0.0 | -0.1 |
Income Before Income Taxes | -1.8 | -2.0 | -1.6 | -2.0 | -2.1 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -1.8 | -2.0 | -1.6 | -2.0 | -2.1 |
Consolidated Net Income / Loss | -1.8 | -2.0 | -1.6 | -2.0 | -2.1 |
Net Income Attributable to Common Shareholders | -1.8 | -2.0 | -1.6 | -2.0 | -2.1 |
Basic EPS | -$0.06 | -$0.06 | -$0.04 | -$0.05 | -$0.06 |
Diluted EPS | -$0.06 | -$0.06 | -$0.04 | -$0.05 | -$0.06 |
Basic Shares Outstanding | 30.1M | 34.5M | 36.0M | 36.4M | 36.4M |
Diluted Shares Outstanding | 30.1M | 34.5M | 36.0M | 36.4M | 36.4M |